Brands: Zestoretic · Hydrochlorothiazide + Lisinopril
Average across 14 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Bryant Ranch Prepack | repackager | 23 | SUPPLYING |
| Proficient Rx LP | repackager | 19 | SUPPLYING |
| NuCare Pharmaceuticals,Inc. | repackager | 15 | SUPPLYING |
| Preferred Pharmaceuticals Inc. | repackager | 12 | SUPPLYING |
| Lupin Pharmaceuticals,Inc. | generic | 9 | SUPPLYING |
| Northwind Health Company, LLC | repackager | 9 | SUPPLYING |
| A-S Medication Solutions | repackager | 8 | SUPPLYING |
| REMEDYREPACK INC. | repackager | 7 | SUPPLYING |
| Aurobindo Pharma Limited | generic | 6 | SUPPLYING |
| Aphena Pharma Solutions - Tennessee, LLC | repackager | 6 | SUPPLYING |
| GSMS, Incorporated | unknown | 6 | SUPPLYING |
| PD-Rx Pharmaceuticals, Inc. | repackager | 6 | SUPPLYING |
| Almatica Pharma LLC | unknown | 3 | SUPPLYING |
| Actavis Pharma, Inc. | generic | 3 | SUPPLYING |
| Legacy Pharmaceutical Packaging, LLC | unknown | 3 | SUPPLYING |
+ 4 more labelers
Shortages, recalls, and registration changes attached to this drug concept.
Product Mix Up: This product is being recalled because of a complaint received that a sealed bottle of lisinopril and hydrochlorothiazide tablets 20mg/12.5 mg had a foreign tablet identified as atazanavir and ritonavir tablet 300mg/100mg. — Recalling firm: Lupin Pharmaceuticals Inc. — Product was distributed nationwide within the United States.
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions. — Recalling firm: CARDINAL HEALTHCARE — Nationwide USA
Presence of Foreign Tablets/Capsules: Product complaint received of one Fenofibrate tablet 145mg observed in 500 s count product bottle. — Recalling firm: Lupin Pharmaceuticals Inc. — Nationwide within the United States
Presence of Foreign Substance; Product complaints received related to brownish/blackish stains on the tablets and brownish/blackish powder observed inside the bottles. — Recalling firm: Lupin Pharmaceuticals Inc. — Product was distributed to wholesalers/distributors and supermarket and drug chains throughout the United States.
CGMP Deviations: finished products manufactured using active pharmaceutical ingredients whose intermediates failed specifications. — Recalling firm: Lupin Pharmaceuticals Inc. — Nationwide and Puerto Rico
